← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Closed-loop transcranial focused ultrasound to restore hippo (PVALB) — 1.00 Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 1.00 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.99 Closed-loop tACS targeting EC-II PV interneurons to suppress (PVALB) — 0.99 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 Beta-frequency entrainment therapy targeting PV interneuron- (SST) — 0.98 LRP1-Dependent Tau Uptake Disruption (LRP1) — 0.98 Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte (SST, SSTR1, SSTR2) — 0.97 Closed-loop tACS targeting EC-II parvalbumin interneurons to (PVALB) — 0.97 PLCG2 Allosteric Modulation as a Precision Therapeutic for T (PLCG2) — 0.94 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.94 Dual-Receptor Antibody Shuttling (?) — 0.94 SASP-Driven Microglial Metabolic Reprogramming in Synaptic P (HK2/PFKFB3) — 0.93 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.93 Closed-loop transcranial alternating current stimulation to (SST) — 0.93 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 Closed-loop tACS targeting entorhinal cortex layer II SST in (SST) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 TREM2-mediated microglial tau clearance enhancement (TREM2) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Alpha-gamma cross-frequency coupling enhancement to restore (SST) — 0.91 TREM2-ASM Crosstalk in Microglial Lysosomal Senescence (SMPD1) — 0.91
Add
|
× Alpha-Beta Oscillation En × Plasma p-tau217-Triggered
SST, CREB1, lncRNA-9969, PGC1α, TFAM, NRF1 · molecular neurobiology · -
Composite 0.000
Price $0.00
Evidence For 4
Evidence Against 5
Closed-loop transcranial focused ultrasound (cl-tFUS) restoring cortical alpha-beta oscillations (8-20 Hz) via somatostatin (SST) interneuron recruitment upregulates lncRNA-9969 expression in SST neurons, enhancing miR-6361 sequestration and mitochondrial biogenesis gene expression including PGC1α, TFAM, and NRF1. This circuit-RNA synergy creates a positive feedback loop: alpha-beta entrainment promotes lncRNA-9969 transcription through CREB activation in SST interneurons, while enhanced mitocho
CSF p-tau217 (biomarker), lncRNA-0021, hUC-MSC exosomes · molecular neurobiology · -
Composite 0.911
Price $0.92
Evidence For 4
Evidence Against 3
CSF p-tau217 serves as a predictive biomarker for optimal lncRNA-0021 (via MSC exosome) therapeutic intervention timing, with the greatest efficacy observed when plasma p-tau217 levels are elevated but before significant neuronal loss (Braak stage III-IV). Implementing p-tau217-guided dosing windows prevents premature treatment termination and allows personalized exosome dosing calibration to maximize miR-6361 sequestration restoration without off-target effects.
Verdict Summary 0/10
dimensions won
Alpha-Beta Oscillation Entrainment Enhan
10/10
dimensions won
Plasma p-tau217-Triggered Exosome Dosing
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Alpha-Beta Oscillation Entrain Plasma p-tau217-Triggered Exos Mechanistic 0.600 0.750 Evidence 0.000 0.700 Novelty 0.000 0.500 Feasibility 0.000 0.850 Impact 0.000 0.650 Druggability 0.400 0.800 Safety 0.400 0.750 Competition 0.500 0.550 Data 0.450 0.750 Reproducible 0.500 0.750
Evidence Alpha-Beta Oscillation Entrainment Enhances lncRNA-9969-Medi Supporting Evidence Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct PV interneuron recruitm PMID:established:world_model hUC-MSC-derived exosomes ameliorate AD pathology through lncRNA-9969-mediated multi-target protection PMID:41540476 Contradicting Evidence Combines two unvalidated products into one combo-product thesis PMID:NA Internal inconsistency: switches from lncRNA-0021 to lncRNA-9969 PMID:NA Device-only program is feasible; RNA-exosome mechanistic overlay is not yet proven PMID:NA Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 Contradicting Evidence H7 is a companion-diagnostics / patient-selection idea, not a new drug mechanism PMID:NA Multiple competitors exist: Quest AD-Detect, C2N PrecivityAD2, ALZpath platform PMID:NA p-tau217 guidance should pair first with Leqembi/Kisunla rather than unvalidated lncRNA-0021 asset PMID:NA Price History Overlay
Shared Evidence
No shared papers found across 0 total unique citations. These hypotheses draw from independent evidence bases.